The current thesis describes the production of a recombinant form of streptolysin-O, appropriate for use in immunoassays, as well as the optimization of the production process in a laboratory fermenter. Determination of anti-streptolysin-O antibody titers is one of the paraclinical assays most often used in the diagnosis of sequelae to Streptococcus-pyogenes infections. To develop diagnostic reagents, it is necessary to obtain streptolysin-O in suitable quantity and quality. Producing streptolysin-O from S. pyogenes cultures is difficult since it requires complex recovery and purification protocols and the yield is low; therefore, large volumes of bacterial culture must be handled. Because of these difficulties, an alternative approach was considered: using recombinant DNA techniques to produce recombinant streptolysin-O protein. This approach allows high yields of proteins using relatively simple purification protocols in better biosafety conditions. This thesis reports the cloning of the streptolysin-O gene from nucleotide 430 to the end of the reading frame, in the expression vector pGEX-2T. Recombinant streptolysin-O protein was expressed in Escherichia coli as a fusion protein with the glutathione Stransferase enzyme of Schistosoma japonicum. In order to increase production of the recombinant protein in E. coli, its expression was studied in cultures in small flasks, analyzing variables such as inducer concentration, induction temperature, proportion of culture medium volume to total flask volume, and different E. coli strains. In a second stage, production was scaled up to fermenter level and optimized; the volumetric rates of oxygen consumption and glucose feeding of the system were analyzed. After cultivation in the fermenter, the recombinant streptolysin-O was recovered and purified by affinity chromatography on a glutathione-Sepharose column. Finally, the stability of the final product in different formulations was
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Immunoblot assays carried out using the recombinant protein demonstrated that it was specifically recognized by human sera positive for anti-streptolysin-O antibodies.
An ELISA was therefore developed to measure anti-streptolysin-O antibody titers in human sera and was compared with a commercial latex kit which used native streptolysin-O as the antigen. Results indicated that the recombinant streptolysin-O was suitable for use in immunoassays. In summary, the results showed that a simple 
